ICYMI: LP-284 Earns Orphan Drug Designation for High-Grade B-Cell Lymphoma with MYC/BCL2 Rearrangements
PDPics / Pixabay

ICYMI: LP-284 Earns Orphan Drug Designation for High-Grade B-Cell Lymphoma with MYC/BCL2 Rearrangements

  Have you ever heard of Orphan Drug designation? This designation, granted by the U.S. Food and Drug Administration (FDA), is given to drugs or biologics that are designed to treat,…

Continue Reading ICYMI: LP-284 Earns Orphan Drug Designation for High-Grade B-Cell Lymphoma with MYC/BCL2 Rearrangements
Enterome Announces Positive Preliminary Trial Data for Non-Hodgkin Lymphoma
mcmurryjulie / Pixabay

Enterome Announces Positive Preliminary Trial Data for Non-Hodgkin Lymphoma

  Enterome presented its findings to the 17th International Conference on Malignant Lymphoma (ICML) in June of this year. As reported in the GlobeNewswire, the company demonstrated that E02463 together…

Continue Reading Enterome Announces Positive Preliminary Trial Data for Non-Hodgkin Lymphoma

CB-010 Shows Promise for B-Cell Non-Hodgkin Lymphoma, Study Shows

Recent results are available from the dose escalation portion of the Phase 1 ANTLER study. In reporting from Targeted Oncology, Jordyn Sava shares that the study included 16 participants living…

Continue Reading CB-010 Shows Promise for B-Cell Non-Hodgkin Lymphoma, Study Shows
White Sox Pitcher Liam Hendriks Returns to Field After Conquering Non-Hodgkin’s Lymphoma (NHL)
Source: pixabay.com

White Sox Pitcher Liam Hendriks Returns to Field After Conquering Non-Hodgkin’s Lymphoma (NHL)

In December 2022, Liam Hendriks—a pitcher for the Chicago White Sox—was diagnosed with non-Hodgkin’s lymphoma (NHL); he shared this news with the world in January 2023, which Patient Worthy reported…

Continue Reading White Sox Pitcher Liam Hendriks Returns to Field After Conquering Non-Hodgkin’s Lymphoma (NHL)
White Sox Relief Pitcher Liam Hendriks Shares Non-Hodgkin’s Lymphoma (NHL) Diagnosis
source: pixabay.com

White Sox Relief Pitcher Liam Hendriks Shares Non-Hodgkin’s Lymphoma (NHL) Diagnosis

  Known as “Slydah,” Chicago White Sox relief pitcher (RP) Liam Hendriks has done amazing things on the field. In September/October 2021, Hendriks was named the American League Reliever of…

Continue Reading White Sox Relief Pitcher Liam Hendriks Shares Non-Hodgkin’s Lymphoma (NHL) Diagnosis
Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
source: pixabay.com

Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma
source: pixabay.com

FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma

The FDA will review parsaclisib as a treatment for Non-Hodgkin lymphoma (NHL) after accepting Incyte's New Drug Application (NDA). Specifically, the NDA was submitted for the treatment of relapsed or…

Continue Reading FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma